Stefani Wolff, Chief Development Officer at Principia Biopharma Inc. (PRNB), sold 9,710 shares at $49.87 ($479K) on 2019-12-16, disclosed to the SEC on 2020-06-17.
Open-market sale of $479k PRNB by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.29 | 4,205 | $207K | 43.2% |
| 2 | $49.29 | 4,205 | $207K | 43.2% |
| 3 | $49.87 | 1,300 | $65K | 13.5% |
| Total | $49.37 avg | 9,710 | $479K | 100% |
| Filing → |
| NRIX | SELL | 2022-11-01 | $5K | — | Filing → |
| NRIX | SELL | 2022-08-02 | $6K | — | Filing → |
| NRIX | SELL | 2022-05-03 | $4K | — | Filing → |